Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

Raziel Therapeutics (RT) Ltd

Home Clinical Trial Sponsors and OrganizationsRaziel Therapeutics (RT) Ltd

Raziel Therapeutics (RT) Ltd

10 Prof. M. Flaut, Rehovot, Shfella Area, Israel

Also known as:

raziel therapeutics ltd

Share to Twitter Share to Facebook Share to LinkedIn Share to Reddit

Clinical Trials

9

0 active

Approvals

0

Total approvals

Agencies

0

Regulatory bodies

Founded

N/A

Overview

Trial Phase Distribution

Phase

Trials

Share

Phase 2

7

77.8%

Phase 1

2

22.2%

Trial Status Distribution

Completed

9

100.0%

Clinical Trials

Trials sponsored by this organization (9)

An Open-label Study That Will Test a Second Treatment Session of RZL-012.

May 202315 participants

Evaluation the Effects of Various Treatments on RZL-012-Induced Adverse Events

Sep 202248 participants

An Open Label Study That Will Test Safety and Efficacy of RZL-012 Injection Into the Submental Fat in Chinese vs. Non-Chinese Subjects.

Jul 202220 participants

Evaluation of Safety and Efficacy of RZL-012 in Subjects Seeking Fat Reduction in the Flanks

Mar 202212 participants

Efficacy and Safety of RZL-012 on Submental Fat Reduction

Jun 2021151 participants

RZL-012 for Dercum's Disease Lipomas

Jul 202038 participants

A Single Blind, Randomized, Placebo-controlled, Phase 2a, 2-cohort Study for the Evaluation of Safety and Efficacy of RZL-012 for Submental Fat Reduction in Healthy Volunteers.

Feb 202028 participants

Treatment of Women With Lipedema Involving Substantial Fat Knee of Women and Men With Nodular Dercum's Disease

Jun 201812 participants

Page 1 of 2

Approvals

No approval data available

News

No news articles found

On this page

Overview
Clinical Trials9
Approvals
News

Back to Organizations